Research for investigating treatment of fulnilnant hepatic failure : An experimental study of auxiliary temporal partial orthotopic liver transplantation using living-donor partial liver

全面性肝衰竭治疗研究:活体部分肝辅助颞部部分原位肝移植的实验研究

基本信息

  • 批准号:
    08557078
  • 负责人:
  • 金额:
    $ 6.27万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1998
  • 项目状态:
    已结题

项目摘要

(Background and Aim) Fulminant hepatic failure has been a fatal disease and has had an extremely poor prognosis. However, prognosis of fulminant failure was recently improved up to 50% of survival after orthotopic liver transplantation. An alternative, auxiliary temporal partial orthotopic liver transplantation (ATPOLT), is mole useful since ATPOLT can allow two liver transplantations and can avoid immunosuppression therapy after recovery of patients. To introduce ATPOLT for fulminant hepatic failure in Japan, living-related partial liver should be introduced. The aim of the present study was to investigate what kinds of supporting therapy are needed for ATPOLT using living-related liver in pigs.(Materials and Methods) Pigs were fed a choline-methionine deficient diet for 2 months. Then, the common bile duct was ligated through laparotomy. A fulminant hepatic failure model was produced 1 week after bile duct ligation (Recipient pigs). The living-related partial left lobe liver was proc … More ured from normal pigs (Donor pigs). ATPOLT was immediately performed for the recipient pigs according to the method of Boudjema et al. In Group A (n = 5), no treatment was added after ATPOLT. In Group B (n = 5), a free radical scavenger, N-acetylcysteine (150 mg/kg/day) and anti-intercellular adhesion molecule 1 monoclonal antibody (0.8 mg/kg/day) were administered day by day after ATPOLT.(Results) In Group A, all pigs died on 3 days after ATPOLT. In Group B, all pigs survived during 3 days after ATPOLT. Serum α-glutathione S transferase concentration, which can indicate hepatocellular injury just before a few hours, was significantly higher in Group A than in Group B after the postoperative day 2 (p<0.05). Prothrombin time, concentrations of serum total bilirubin, that of serum reduced glutathione were significantly improved in Group B than in Group B.(Conclusion) As shown in Group A, ATPOLT could not result in long-term survival in pigs with fulminant hepatic failure. However, immediate treatment using the free radical scavenger and the monoclonal antibody inhibiting adhesion between neutrophils and endothelial cells can inhibit non-function of the graft liver and can allow long-term survival of the animals with fulminant hepatic failure. Less
(背景和目的)暴发性肝衰竭是一种致命的疾病,预后极差,但最近在原位肝移植后,暴发性肝衰竭的生存率提高了 50%。 (ATPOLT),是摩尔有用的,因为 ATPOLT 可以允许两次肝移植,并且可以避免患者康复后的免疫抑制治疗。日本爆发性肝衰竭,应引入活体部分肝,本研究的目的是探讨使用活体相关肝对猪进行 ATPOLT 需要什么样的支持治疗。(材料与方法)胆碱-蛋氨酸缺乏饮食2个月,然后通过剖腹手术结扎胆总管,建立暴发性肝衰竭模型。 (受体猪)从正常猪(供体猪)中获取活体相关的部分左叶肝脏,并根据 Boudjema 等人的方法立即对受体猪进行 ATPOLT。 ),B组(n = 5)后不添加自由基清除剂,N-乙酰半胱氨酸(150 mg/kg/天)和抗细胞间质瘤。 ATPOLT后逐日给予粘附分子1单克隆抗体(0.8mg/kg/天)。(结果)A组所有猪均在ATPOLT后3天内死亡。B组所有猪在ATPOLT后3天内均存活。术后第 2 天后,A 组的血清 α-谷胱甘肽 S 转移酶浓度显着高于 B 组,该浓度可表明几小时前的肝细胞损伤(p<0.05) B组的凝血酶原时间、血清总胆红素浓度、血清还原型谷胱甘肽浓度均较B组显着改善。(结论)如A组所示,ATPOLT不能导致患者长期生存。然而,患有暴发性肝衰竭的猪,立即使用自由基清除剂和抑制中性粒细胞与内皮细胞之间粘附的单克隆抗体进行治疗可以抑制肝功能的丧失。移植肝脏可以使患有暴发性肝衰竭的动物长期存活。

项目成果

期刊论文数量(45)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Nakano H,et al.: "Dextran sulfate inhibits E-selectin-mediated neutrophil adhesion to endotoxin-activated vascular endothelial cells" Life Sci.64. 9-17 (1998)
Nakano H 等人:“硫酸葡聚糖抑制 E-选择素介导的中性粒细胞与内毒素激活的血管内皮细胞的粘附”Life Sci.64。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Takeuchi S, Nakano H, et al.: "Predicting Survival and Postoperative Complications with Tc-GSA Liver Scintigraphy in Hepatocellular Carcinoma"Hepatogastroenterology. 46. 1855-61 (1999)
Takeuchi S、Nakano H 等人:“利用 Tc-GSA 肝脏闪烁扫描术预测肝细胞癌的生存和术后并发症”肝胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Baek Y, Nakano H, et al.: "Administration of Prostaglandin E1 Reduces Postoperative Hepatocellular Damage and Restores Hepatic Integrity in Patients Undergoing Hepatectomy"Hepatogastroenterology. 46. 1836-41 (1999)
Baek Y、Nakano H 等人:“给予接受肝切除术的患者服用前列腺素 E1 可减少术后肝细胞损伤并恢复肝脏完整性”肝胃肠病学。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Kigawa G, Nakano H, et al.: "Improvement of portal hepatic microcirculatory tissue flow with N-acetylcysteine in dogs with obstructive jaundice produced by bile duct ligation"Eur J Surg. 166. 77-84 (2000)
Kikawa G、Nakano H 等人:“用 N-乙酰半胱氨酸改善因胆管结扎引起的梗阻性黄疸犬的门肝微循环组织流动”Eur J Surg。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Nakano H,et al: "Prognostic ebaluation of locally advanced gastric cancer patients with preoperative downstaging chemotherapy." Cancer Detect Prev. 20. 447-448 (1996)
Nakano H 等人:“术前降期化疗的局部晚期胃癌患者的预后评估。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

NAKANO Hiroshi其他文献

NAKANO Hiroshi的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('NAKANO Hiroshi', 18)}}的其他基金

Empirical study for bringing up ability to solve a problem by applying a having learned matter
培养运用所学知识解决问题的能力的实证研究
  • 批准号:
    22500798
  • 财政年份:
    2010
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Proteomics analysis of a mechanism of sinusoidal endothelial cell injury after receiving oxaliplatin-based chemotherapy in colorectal liver metastases.
结直肠肝转移瘤接受奥沙利铂化疗后肝窦内皮细胞损伤机制的蛋白质组学分析。
  • 批准号:
    22591509
  • 财政年份:
    2010
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of a Context-aware Authoring Tool for Simulation Learning Materials
开发模拟学习材料的情境感知创作工具
  • 批准号:
    21500946
  • 财政年份:
    2009
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The molecular mechanisms of chronic exercise to improve the developmental disorders
长期运动改善发育障碍的分子机制
  • 批准号:
    21500642
  • 财政年份:
    2009
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Cytokine Immuno-gene Therapy Against Head and Neck Squamous Cell Carcinoma
头颈鳞状细胞癌的细胞因子免疫基因治疗
  • 批准号:
    21791632
  • 财政年份:
    2009
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Empirical study on arithmetic department class that intends understanding and use of mathematical principle.
旨在理解和运用数学原理的算术系课堂的实证研究。
  • 批准号:
    19500713
  • 财政年份:
    2007
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic approach against surgical injury of diseased liver : Proteomics approach
针对病变肝脏手术损伤的治疗方法:蛋白质组学方法
  • 批准号:
    18591528
  • 财政年份:
    2006
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modification of the Hepatic Mitochondrial Proteome in Response to Ischemic Preconditioning Following Ischemia-Reperfusion Injury of the Rat Steatotic Liver.
大鼠脂肪肝缺血再灌注损伤后肝线粒体蛋白质组的修饰对缺血预处理的反应。
  • 批准号:
    16591367
  • 财政年份:
    2004
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Practical Approach to Teaching Scientific Fundamentals from Computer Mechanisms using Multimedia
使用多媒体教授计算机机制科学基础知识的实用方法
  • 批准号:
    15606012
  • 财政年份:
    2003
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
EFFECT OF ACETOALDEHYDE ON THE GENE EXPRESSION OF TYPE IV COLLAGENASES AND THOSE INHIBITORS IN CULTURED HUMAN ITO-CELLS
乙醛对培养的人类 ITO 细胞中 IV 型胶原酶和抑制剂基因表达的影响
  • 批准号:
    08670613
  • 财政年份:
    1996
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)

相似国自然基金

谷胱甘肽S-转移酶在射血分数保留型心力衰竭的作用及机制研究
  • 批准号:
    82300426
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
谷胱甘肽-S-转移酶基因SiGSTU24介导H2O2信号通路调控谷子耐盐性的分子机制研究
  • 批准号:
    32301779
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
谷胱甘肽S-转移酶荧光探针的研制及其在农业害虫抗性检测中的应用
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    54 万元
  • 项目类别:
    面上项目
谷胱甘肽S-转移酶NnGST1与NnGST2介导莲花瓣花青素苷转运的机制解析
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
高血压肥厚心肌纤维化调控的新机制:谷胱甘肽S转移酶/Oplah代谢通路的关键作用
  • 批准号:
    U21A20341
  • 批准年份:
    2021
  • 资助金额:
    260 万元
  • 项目类别:

相似海外基金

閉塞性黄疸外科的侵襲時の病態解析と治療法の研究:実験と臨床応用についての検討
手术侵袭性梗阻性黄疸的病理分析及治疗方法研究:实验与临床应用的思考
  • 批准号:
    10671217
  • 财政年份:
    1998
  • 资助金额:
    $ 6.27万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了